HCR Wealth Advisors’s Verastem VSTM Stock Holding History

HCR Wealth Advisors’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-833	Closed	-$17K	–	262
2020 Q2	$17K	Buy	+833	New	+$22K	﹤0.01%	211

Other funds holding VSTM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCM

Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HCR Wealth Advisors's VSTM Position: Q3 2020 in Review

HCR Wealth Advisors sold out of Verastem (VSTM) in Q3 2020, closing a stake of 833 shares — an estimated $17K sold.

HCR Wealth Advisors first reported a position in VSTM in Q2 2020 and held it in 1 quarter. The position peaked at $17K in Q2 2020. 122 funds tracked by Wall St. Rank hold VSTM as of Q3 2020.

HCR Wealth Advisors reported no remaining Verastem position as of Q3 2020 after selling out during the quarter.
HCR Wealth Advisors sold 833 Verastem shares in Q3 2020, an estimated $17K.
HCR Wealth Advisors first reported a position in Verastem in Q2 2020 and held it in 1 quarter.
HCR Wealth Advisors's Verastem position peaked at $17K in Q2 2020.
122 funds tracked by Wall St. Rank held Verastem as of Q3 2020.

Based on HCR Wealth Advisors's 13F filing for Q3 2020, filed 5 Nov 2020.